# Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy

> **NCT02199613** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 10 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Treatment simplification

## Key facts

- **NCT ID:** NCT02199613
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-02-14
- **Final completion:** 2017-02-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199613, "Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02199613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*